Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytoskeletal and Junctional Proteins encompass a diverse group of structural and regulatory proteins that maintain cellular architecture and facilitate communication between cells and the extracellular matrix. The cytoskeleton is composed of three primary filament systems—microfilaments (actin), intermediate filaments (e.g., keratins, lamins), and microtubules (tubulin)—which are essential for cell division, intracellular transport, and motility (UniProt). Junctional proteins, including cadherins, claudins, and integrins, form specialized structures like tight junctions and desmosomes that ensure tissue integrity and regulate paracellular transport (StatPearls). In disease states, particularly oncology, the remodeling of these proteins is a key driver of the epithelial-mesenchymal transition (EMT), enabling tumor invasion and metastasis (PubMed). Pharmacological intervention typically targets specific subunits, such as microtubule-stabilizing agents (taxanes) used in cancer or integrin antagonists used in autoimmune and inflammatory conditions (NIH). Due to the fundamental and ubiquitous nature of these proteins across all tissue types, therapeutic development faces significant challenges in achieving tissue-specific delivery and minimizing systemic side effects.
Modulation of protein polymerization (e.g., microtubule stabilization or destabilization) and inhibition of cell-cell or cell-matrix adhesion through competitive binding to junctional receptors.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytoskeletal and Junctional Proteins.